Meribank targets biomedicine with AI and semiconductors

Meribank, a company specializing in semiconductor manufacturing, is expanding its reach to the biomedical sector. The company intends to leverage its expertise in the fabrication of precision components, combining it with artificial intelligence and a modular approach to processes.

The goal is to improve diagnostic and therapeutic capabilities, bringing the precision typical of the semiconductor industry to the field of medicine. No details are specified on the hardware or the type of AI models used, but the initiative suggests a growing convergence between technology and life sciences.